Gene · 8030
Papers1,913
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,913
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Fine-tuning of Wnt signaling by RNA surveillance factor Smg5 in the mouse craniofacial development. | iScience | 2025 | 40071146 | PubTator, text mining | PubMed |
| Decoding heterogeneous single-cell perturbation responses. | Nat Cell Biol | 2025 | 40011559 | PubTator, text mining | PubMed |
| Personalized Therapy in a Patient With EGFR-Mutated NSCLC Developing Sequential CCDC6-RET Fusion and BRAF V600E Mutation as Bypass Resistance Mechanisms. | JTO Clin Res Rep | 2025 | 39990136 | PubTator, text mining | PubMed |
| Clinical, Morphologic, and Genomic Findings in Spitz Tumors With RET Fusion: A Series of 31 Cases. | Mod Pathol | 2025 | 39986469 | PubTator, text mining | PubMed |
| Molecular Subtyping and Genomic Profiling Expand Precision Medicine in KRAS Wild-Type Pancreatic Cancer. | Cancer Sci | 2025 | 39833990 | PubTator, text mining | PubMed |
| RET-AREAL: A multi-center, real-world data analysis on the efficacy of pralsetinib in acquired RET fusion after resistance to EGFR/ALK-TKIs. | Cancer Lett | 2025 | 39800214 | PubTator, text mining | PubMed |
| Confirmatory Factor Analysis and Propensity to Cheat Scale Validation in the Ethiopian Public Higher Education Institutions. | F1000Res | 2024 | 40880609 | PubTator, text mining | PubMed |
| Functional Targets for Epstein-Barr Virus BART MicroRNAs in B Cell Lymphomas. | Cancers (Basel) | 2024 | 39456631 | PubTator, text mining | PubMed |
| Descriptive Analysis of Common Fusion Mutations in Papillary Thyroid Carcinoma in Hungary. | Int J Mol Sci | 2024 | 39409115 | PubTator, text mining | PubMed |
| A supramolecular fluorescence probe that simultaneously responds to viscosity and G-quadruplex for autophagy detection. | Anal Chim Acta | 2024 | 39396306 | PubTator, text mining | PubMed |
| Diagnosis, Treatment Patterns, and Outcomes in Real-World Patients with RET Fusion-Positive Non-small Cell Lung Cancer in China. | Adv Ther | 2024 | 39316291 | PubTator, text mining | PubMed |
| Clinicopathological Features of CCDC6-RET and NCOA4-RET Fusions in Thyroid Cancer: A Single-Center Retrospective Cohort Study in a Chinese Population. | Thyroid | 2024 | 39212716 | PubTator, text mining | PubMed |
| A double-edged sword: unusual multiple severe infections with pralsetinib: a case report and literature review. | Front Med (Lausanne) | 2024 | 39139787 | PubTator, text mining | PubMed |
| Low-dose ionizing radiation-induced RET/PTC1 rearrangement via the non-homologous end joining pathway to drive thyroid cancer. | MedComm (2020) | 2024 | 39135916 | PubTator, text mining | PubMed |
| Single nucleotide and copy number variants of cancer driver genes inform drug response in multiple cancers. | PLoS One | 2024 | 39083502 | PubTator, text mining | PubMed |
| A post-irradiation-induced replication stress promotes RET proto-oncogene breakage. | Eur Thyroid J | 2024 | 39047147 | PubTator, text mining | PubMed |
| Combined Dacomitinib and Selpercatinib Treatment for a Patient with EGFR-Mutant Non-Small Cell Lung Cancer and Acquired CCDC6-RET Fusion. | Onco Targets Ther | 2024 | 38911906 | PubTator, text mining | PubMed |
| A Biphasic Strategy to Synergistically Accelerate Activation and CO Spillover in Formic Acid Oxidation Catalysis. | Nano Lett | 2024 | 38900138 | PubTator, text mining | PubMed |
| Difficulties of Preoperative Diagnosis of Cribriform Morular Thyroid Carcinoma. | Case Rep Endocrinol | 2024 | 38835742 | PubTator, text mining | PubMed |
| CCDC6-RET fusion protein regulates Ras/MAPK signaling through the fusion- GRB2-SHC1 signal niche. | Proc Natl Acad Sci U S A | 2024 | 38805286 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8030/papers?page=6